Clean Science invests Rs 50 Cr in Clean Fino-Chem via rights issue
Clean Science and Technology Limited subscribed to 8,36,121 equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, for Rs 50,00,00,358 through a rights issue. The shares were issued at a face value of Rs 10 each with a premium of Rs 588 per share. The funds will primarily be used for funding the subsidiary's projects in the speciality chemicals industry.

*this image is generated using AI for illustrative purposes only.
Clean Science and Technology Limited has subscribed to 8,36,121 equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, via a rights issue. The subscription amount totals Rs 50,00,00,358, comprising shares of Rs 10 each at a premium of Rs 588 per share. This capital infusion is intended to fund the projects of the subsidiary, which operates in the speciality chemicals sector.
Transaction Details
The rights issue was fully subscribed by the parent company, ensuring the transaction was conducted at arm’s length. Clean Fino-Chem Limited, incorporated on March 22, 2022, remains a wholly-owned subsidiary following this investment.
| Parameter | Details |
|---|---|
| Subsidiary Name | Clean Fino-Chem Limited |
| Ownership | Wholly-owned subsidiary |
| Mode of Infusion | Rights Issue |
| Shares Subscribed | 8,36,121 Equity Shares |
| Face Value | Rs 10 per share |
| Premium | Rs 588 per share |
| Total Amount | Rs 50,00,00,358 |
Financial Performance
Clean Fino-Chem Limited has reported a significant increase in turnover over the last three financial years. The company recorded a turnover of Rs 166 crore for the year ended March 31, 2026, compared to Rs 46.77 crore in the previous year and Rs 1.92 crore in the year ended March 31, 2024.
Historical Stock Returns for Clean Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.21% | +0.05% | +2.95% | -13.14% | -46.30% | -50.86% |
What specific projects will the Rs 500 crore capital infusion target, and what is the expected timeline for completion?
How will this investment impact Clean Science and Technology's leverage ratios and overall cash flow position in the coming fiscal year?
Given the subsidiary's rapid revenue growth, what are the projected profit margins once the newly funded projects become operational?

































